New Treatments in Renal Cancer: The AhR Ligands

Kidney cancer rapidly acquires resistance to antiangiogenic agents, such as sunitinib, developing an aggressive migratory phenotype (facilitated by c-Metsignal transduction). The Aryl hydrocarbon receptor (AhR) has recently been postulated as a molecular target for cancer treatment. Currently, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Itkin, Boris, Breen, Alastair, Turyanska, Lyudmila, Sandes, Eduardo Omar, Bradshaw, Tracey D., Loaiza-Perez, Andrea Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279047/
https://www.ncbi.nlm.nih.gov/pubmed/32443455
http://dx.doi.org/10.3390/ijms21103551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279047/
https://www.ncbi.nlm.nih.gov/pubmed/32443455
http://dx.doi.org/10.3390/ijms21103551

Ejemplares similares